Optimal Control of Tumor Growth Model with Dendritic Cells as Immunotherapy
DOI:
https://doi.org/10.21776/ub.jels.2018.008.02.06Abstract
In this paper, optimal control of tumor growth model with dendritic cells as immunotherapy is provided. The model equation can be expressed into a nonlinear differential equation system consisting of four compartments namely, tumor cells, CTL cells, helper T cells, and dendritic cells. Dendritic cells as immunotherapy are injected to the body at time t. The aim of this optimal control is to minimize the tumor cells density as well as the cost of dendritic cells to be administered to the body.Optimal control problem is carried out based on Pontryagin's maximum principle and numerical simulation is solved by using Forward-Backward Sweep methods. Simulation results show that control strategy shrinks tumor cells density which is shown by tumor cells density graph that monotonically decreases after applying dendritic cells as immunotherapy.
Keywords: immunotherapy, optimal control, Tumor cell.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
